Implication of hepatokines in metabolic disorders and cardiovascular diseases
BBA Clinical · 2016-06 · 5 · 108-113
DOI: 10.1016/j.bbacli.2016.03.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BBA Clinical, 2016-06. Verfasst von Tae Woo Jung und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Republic of Korea. Die Arbeit wurde bisher 67-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Korea University, Seoul, Republic of Korea.
Förderung
- Korean Health Technology R&D Project
- Ministry of Health & Welfare
- Republic of Korea
Zitieren
APA
Jung, T. W., Yoo, H. J., & Choi, K. M. (2016). Implication of hepatokines in metabolic disorders and cardiovascular diseases. BBA Clinical, 5, 108-113. https://doi.org/10.1016/j.bbacli.2016.03.002
Vancouver
Jung TW, Yoo HJ, Choi KM. Implication of hepatokines in metabolic disorders and cardiovascular diseases. BBA Clinical. 2016;5:108-113. doi:10.1016/j.bbacli.2016.03.002
BibTeX
@article{Jung2016,
author = {Jung, Tae Woo and Yoo, Hye Jin and Choi, Kyung Mook},
title = {Implication of hepatokines in metabolic disorders and cardiovascular diseases},
journal = {BBA Clinical},
year = {2016},
volume = {5},
pages = {108--113},
doi = {10.1016/j.bbacli.2016.03.002}
}
EUVIMED